Status:
COMPLETED
AI-based Frailty Assessment Tool for Patients Undergoing Cardiac Surgery
Lead Sponsor:
China National Center for Cardiovascular Diseases
Conditions:
Frailty
Eligibility:
All Genders
18+ years
Brief Summary
The main purpose of this study is to establish a frailty automatic evaluation index "AI frailty index" based on artificial intelligence multi-modal non-contact monitoring information analysis. At the ...
Detailed Description
This is a prospective cohort study. Patients who undergoes elective cardiac surgery will be enrolled. We collect frailty scales, clinical information and multi-modal, non-contact monitoring informatio...
Eligibility Criteria
Inclusion
- Elective cardiac surgery
Exclusion
- Emergency surgery
- Age ≤ 18 years
- The clinical situation is unstable, such as frequent occurrence of coronary ischemia events, unstable heart failure, or acute events leading to severe discomfort symptoms or changes in vital signs
- Unable to cooperate in completing research data collection due to severe neurological and psychiatric abnormalities or other reasons
- Duration of postoperative ventilation \> 48 hours or inability to obtain scale data on the first day after surgery
Key Trial Info
Start Date :
May 11 2023
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
December 31 2024
Estimated Enrollment :
521 Patients enrolled
Trial Details
Trial ID
NCT06096922
Start Date
May 11 2023
End Date
December 31 2024
Last Update
May 28 2025
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Fuwai hospital
Beijing, Beijing Municipality, China, 100032